The plasmids
PB-TO-hNGN2 (Addgene plasmid #172115), PB-TO-hNIL (NGN2, ISL1, and LHX3, Addgene plasmid #172113), EFa1-Transposase (Addgene plasmid #172116) were used for transcription factor-based differentiation experiments. For the p53 reporter assay performed on all sub-lines, the PG13-mCherry p53 reporter plasmid was generated by replacing the luciferase sequence of PG13-Luc reporter plasmid
61 (link) (Addgene), which contains 13 copies of a p53-binding site followed by the polyoma promoter, with the mCherry sequence by the
In-Fusion HD Cloning Plus kit (Takara). For the transposon-based p53 reporter assay performed on KOLF2.1J, the pCMV-hyPBase plasmid was obtained from Wellcome Trust Sanger Institute.
62 (link) The PB-PG13-mCherry-EF1a-PuroR-EGFP plasmid, generated by inserting the PG13-mCherry sequence into the PB-EF1a-PuroR-EGFP plasmid (H Oguro, unpublished), contains the PiggyBac 3’-inverted terminal repeat (PB 3’ITR), 5’-HS4 chicken β-globin (cHS4) insulator, PG13-mCherry reporter, woodchuck hepatitis virus post-transcriptional regulatory element (WPRE), bovine growth hormone polyadenylation signal (BGHpA), EF1α promoter, puromycin registrant gene, P2A peptide, EGFP, BGHpA, cHS4 insulator, and PB 5’ITR, in this order.
Pantazis C.B., Yang A., Lara E., McDonough J.A., Blauwendraat C., Peng L., Oguro H., Kanaujiya J., Zou J., Sebesta D., Pratt G., Cross E., Blockwick J., Buxton P., Kinner-Bibeau L., Medura C., Tompkins C., Hughes S., Santiana M., Faghri F., Nalls M.A., Vitale D., Ballard S., Qi Y.A., Ramos D.M., Anderson K.M., Stadler J., Narayan P., Papademetriou J., Reilly L., Nelson M.P., Aggarwal S., Rosen L.U., Kirwan P., Pisupati V., Coon S.L., Scholz S.W., Priebe T., Öttl M., Dong J., Meijer M., Janssen L.J., Lourenco V.S., van der Kant R., Crusius D., Paquet D., Raulin A.C., Bu G., Held A., Wainger B.J., Gabriele R.M., Casey J.M., Wray S., Abu-Bonsrah D., Parish C.L., Beccari M.S., Cleveland D.W., Li E., Rose I.V., Kampmann M., Aristoy C.C., Verstreken P., Heinrich L., Chen M.Y., Schüle B., Dou D., Holzbaur E.L., Zanellati M.C., Basundra R., Deshmukh M., Cohen S., Khanna R., Raman M., Nevin Z.S., Matia M., Van Lent J., Timmerman V., Conklin B.R., Chase K.J., Zhang K., Funes S., Bosco D.A., Erlebach L., Welzer M., Kronenberg-Versteeg D., Lyu G., Arenas E., Coccia E., Sarrafha L., Ahfeldt T., Marioni J.C., Skarnes W.C., Cookson M.R., Ward M.E, & Merkle F.T. (2022). A reference human induced pluripotent stem cell line for large-scale collaborative studies. Cell stem cell, 29(12), 1685-1702.e22.